A matter of motion or an emotional matter? Management of depression in Parkinson's disease (Q36307871)

13 August 2017

1 reference

title

A matter of motion or an emotional matter? Management of depression in Parkinson's disease (English)

1 reference

13 August 2017

1 reference

Gin S Malhi

1 reference

13 August 2017

Jim Lagopoulos

1 reference

13 August 2017

Belinda Ivanovski

series ordinal

1 reference

13 August 2017

Catherine M Cahill

series ordinal

1 reference

13 August 2017

John G L Morris

series ordinal

1 reference

13 August 2017

publication date

1 November 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

803-810

1 reference

An essay on the shaking palsy. 1817.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Range of neuropsychiatric disturbances in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

The neuropsychiatry of Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

The occurrence of depression in Parkinson's disease. A community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson's disease: a discriminant analytic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Disease-specific properties of the Rating Scale for Depression in patients with stroke, Alzheimer's dementia, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Depression in Parkinson's disease: clinical correlates and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Non-recognition of depression and other non-motor symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

The quality of life in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Cognitive impairments and depression in Parkinson's disease: a follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Depression in Parkinson's disease: a quantitative and qualitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Increased risk of Parkinson's disease after depression: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

The pre-morbid personality of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

The correlation of depression with functional activity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

The neuropathology of aminergic nuclei in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Altered serotonin metabolism in depressed patients with parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

High and low affinity [3H]imipramine binding sites in control and parkinsonian brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Development of quality of care indicators for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Prevalence, etiology, and treatment of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Maintenance ECT in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Therapeutic application of repetitive transcranial magnetic stimulation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Self-Reported Mood Changes following 6 Months of Vagus Nerve Stimulation in Epilepsy Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

Vagus nerve stimulation is associated with mood improvements in epilepsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

RECOGNIZING THE ANXIOUS FACE OF DEPRESSION

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.6.803

21 January 2018

Identifiers

DOI

10.1586/14737175.5.6.803

1 reference

13 August 2017

1 reference